Cantor Fitzgerald raised the firm’s price target on PTC Therapeutics (PTCT) to $113 from $76 and keeps an Overweight rating on the shares. PTC ...

Cantor Fitzgerald reiterated an Overweight rating on Tenet Healthcare (NYSE:THC) with a price target of $177.00. The firm's analyst, Sarah James, noted stability in the company's fourth quarter 2024 ...

Cantor Fitzgerald reaffirmed its Overweight rating on Surgery Partners (NASDAQ:SGRY) with a steady price target of $36.00. The stock, which has shown significant momentum with a 20% return over the ...

Equities research analysts at Cantor Fitzgerald raised their FY2025 earnings per share (EPS) estimates for shares of Check Point Software Technologies in a note issued to investors on Friday, January ...

Will the Senate GOP confirm controversial picks like Tulsi Gabbard and RFK Jr.? Here’s the hearings schedule and list of ...

PLTR stock reports Q4 earnings on Monday. Stock is up 393.36% over past year, 9.71% YTD. Technicals are bullish, but analysts ...